Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs
The Journal of clinical investigation (2000) - Comments
pubmed: 10683383  doi: 10.1172/jci8625  issn: 0021-9738 

Mikhail V. Blagosklonny, Robert Robey, Susan Bates, Tito Fojo